Advertisement

Topics

FDA clears hepatitis C drug Mavyret

16:00 EDT 3 Aug 2017 | Drug Store News
The FDA said that Mavyret is the first treatment of eight-week duration for all hepatitis C genotypes.

read more

Original Article: FDA clears hepatitis C drug Mavyret

NEXT ARTICLE

More From BioPortfolio on "FDA clears hepatitis C drug Mavyret"

Quick Search
Advertisement
 

Relevant Topic

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...